Skip to content
Review Open access

Cellular Senescence in Diabetic Kidney Disease: Mechanisms and Treatments

Oct 2026 · Integrative Medicine in Nephrology and Andrology · Vol 13 · 0 citations · 120 references

TL;DR

The fundamental characteristics and major classifications of cellular senescence are summarized; its physiological and pathological functions are discussed, together with the underlying molecular regulatory mechanisms; the role of senescence in renal cell injury during DKD progression is examined; and recent advances in senescence-targeted therapeutic strategies for DKD are highlighted.

Abstract

Cellular senescence refers to a state of stable and essentially irreversible cell cycle arrest, accompanied by extensive changes in cellular secretory activity. Senescent cells accumulate within tissues during physiological aging and in response to various forms of cellular stress or injury. While transient senescence is essential for processes such as embryonic development, tissue regeneration, and tumor suppression, the persistent retention of senescent cells has been increasingly recognized as a key driver of aging and age-related diseases. Diabetic kidney disease (DKD), a prevalent chronic complication of diabetes, is characterized by accelerated renal cellular senescence and progressive accumulation of senescent cells, both of which contribute to structural damage and functional deterioration of the kidney. These observations have positioned cellular senescence as a promising therapeutic target for slowing the onset and progression of DKD. This review summarizes the fundamental characteristics and major classifications of cellular senescence; discusses its physiological and pathological functions, together with the underlying molecular regulatory mechanisms; examines the role of senescence in renal cell injury during DKD progression, and highlights recent advances in senescence-targeted therapeutic strategies for DKD.

Read PDF

Similar papers

Review Open access Sep 2026

Cellular senescence of renal tubular epithelial cells in diabetic kidney disease: emerging mechanisms and targeted interventions

Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease (ESKD), and while current standard treatment strategies can slow disease progression, they are still unable to reverse progressive structural damage to the kidneys. Emerging evidence indicates that the senescence of renal tubular epithelial ce...

Jun-Wei Shi, Jia-Ning Sun, Jun-Wei Gao et al. · 0 citations
Review Open access Sep 2026

The role of senescence in kidney ageing, injury and fibrosis.

Current evidence of senescence as a driver of kidney disease and its potential as a therapeutic target is examined.

Piotr P. Janas, Tilly Mason, D. Ferenbach · 0 citations
Review Oct 2026

Cellular Senescence in Skeletal Muscle: Molecular Mechanisms, Physiological Consequences, and Therapeutic Opportunities.

Cellular senescence is a stress-responsive cell fate characterized by stable growth arrest and acquisition of a proinflammatory senescence-associated secretory phenotype. Senescent cells accumulate with advancing age and contribute to dysfunction and disease across multiple organ systems. In skeletal muscle (SkM), emer...

Rylee Kopchak, N. Lebrasseur · 0 citations
Review Open access Oct 2026

Cellular senescence: six decades of discovery and reinvention.

Cellular senescence has undergone a remarkable conceptual evolution since its discovery in 1961. Initially described by Hayflick and Moorhead as the finite proliferative lifespan of cultured human cells, senescence was first viewed as a consequence of cellular aging. The identification of telomere shortening, senescenc...

Myrthe Klaver, L. S. Steeneken, Naomi Veeningen et al. · 0 citations
Review Open access Oct 2026

Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease where chronological aging predicts the conversion to progressive MS (PMS), a phase defined by compartmentalized inflammation and accelerated neurodegeneration. While current disease modifying therapies (DMTs) are effective for managing the inflamma...

Ala' Yousef, John M. Seubert, Christopher Power et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.